Magnetization transfer ratio and myelin in postmortem multiple sclerosis brain
暂无分享,去创建一个
[1] L. S. King,et al. OBSERVATIONS ON THE HISTOPATHOLOGY OF THE CEREBRAL LESIONS IN DISSEMINATED SCLEROSIS , 1936 .
[2] K. Misulis,et al. DEMYELINATING diseases. , 1952, Lancet.
[3] W. L. Benedict,et al. Multiple Sclerosis , 2007, Journal - Michigan State Medical Society.
[4] P. J. Huber. The behavior of maximum likelihood estimates under nonstandard conditions , 1967 .
[5] J. Kurtzke. Rating neurologic impairment in multiple sclerosis , 1983, Neurology.
[6] Robert N. Holdefer,et al. Quantitative immunocytochemistry using an image analyzer. I. Hardware evaluation, image processing, and data analysis , 1988, Journal of Neuroscience Methods.
[7] G Johnson,et al. Precise relaxation time measurements of normal‐appearing white matter in inflammatory central nervous system disease , 1989, Magnetic resonance in medicine.
[8] D. N. Landon,et al. Duration and selectivity of blood-brain barrier breakdown in chronic relapsing experimental allergic encephalomyelitis studied by gadolinium-DTPA and protein markers. , 1990, Brain : a journal of neurology.
[9] D.L. Plummer,et al. DispImage: Un mezzo di analisi e presentazione per iconografia medica , 1992 .
[10] E. Cho,et al. Multiple sclerosis: Remyelination of nascent lesions: Remyelination of nascent lesions , 1993 .
[11] E. Cho,et al. Multiple sclerosis: remyelination of nascent lesions. , 1993, Annals of neurology.
[12] J. Taubenberger,et al. Correlation between magnetic resonance imaging findings and lesion development in chronic, active multiple sclerosis , 1993, Annals of neurology.
[13] A. MacKay,et al. In vivo visualization of myelin water in brain by magnetic resonance , 1994, Magnetic resonance in medicine.
[14] G. Barker,et al. An interleaved sequence for accurate and reproducible clinical measurement of magnetization transfer ratio. , 1996, Magnetic resonance imaging.
[15] S. Reingold,et al. Defining the clinical course of multiple sclerosis , 1996, Neurology.
[16] Hans Lassmann,et al. Inflammatory central nervous system demyelination: Correlation of magnetic resonance imaging findings with lesion pathology , 1997, Annals of neurology.
[17] V. Perry,et al. Axonal damage in acute multiple sclerosis lesions. , 1997, Brain : a journal of neurology.
[18] F. Barkhof,et al. Histopathologic correlate of hypointense lesions on T1-weighted spin-echo MRI in multiple sclerosis , 1998, Neurology.
[19] R. Rudick,et al. Axonal transection in the lesions of multiple sclerosis. , 1998, The New England journal of medicine.
[20] M. Bronskill,et al. Characterizing white matter with magnetization transfer and T2 , 1999, Magnetic resonance in medicine.
[21] F. Barkhof,et al. Axonal loss in multiple sclerosis lesions: Magnetic resonance imaging insights into substrates of disability , 1999, Annals of neurology.
[22] Gentleman,et al. A comparison of manual and semi‐automated methods in the assessment of axonal injury , 1999, Neuropathology and applied neurobiology.
[23] P. Valk,et al. Staging of multiple sclerosis (MS) lesions: pathology of the time frame of MS. , 2000 .
[24] P M Matthews,et al. Proton MR spectroscopy in multiple sclerosis. , 2000, Neuroimaging clinics of North America.
[25] K P Whittall,et al. Different magnetization transfer effects exhibited by the short and long T2 components in human brain , 2000, Magnetic resonance in medicine.
[26] B K Rutt,et al. Magnetization transfer and multicomponent T2 relaxation measurements with histopathologic correlation in an experimental model of MS , 2000, Journal of magnetic resonance imaging : JMRI.
[27] W. Brück,et al. Acute axonal injury in multiple sclerosis. Correlation with demyelination and inflammation. , 2000, Brain : a journal of neurology.
[28] Nikos Evangelou,et al. Quantitative pathological evidence for axonal loss in normal appearing white matter in multiple sclerosis , 2000, Annals of neurology.
[29] C. D. DE GROOT,et al. Staging of multiple sclerosis (MS) lesions: pathology of the time frame of MS , 2000, Neuropathology and applied neurobiology.
[30] J Carpenter,et al. Bootstrap confidence intervals: when, which, what? A practical guide for medical statisticians. , 2000, Statistics in medicine.
[31] I. V. Allen,et al. Pathological abnormalities in the normal-appearing white matter in multiple sclerosis , 2001, Neurological Sciences.
[32] A. Compston,et al. Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis , 2001, Annals of neurology.
[33] R. Henkelman,et al. Magnetization transfer in MRI: a review , 2001, NMR in biomedicine.
[34] F Barkhof,et al. Post-mortem MRI-guided sampling of multiple sclerosis brain lesions: increased yield of active demyelinating and (p)reactive lesions. , 2001, Brain : a journal of neurology.
[35] G J Parker,et al. Accurate multislice gradient echo T1 measurement in the presence of non‐ideal RF pulse shape and RF field nonuniformity , 2001, Magnetic resonance in medicine.
[36] P Kapeller,et al. Brain metabolite changes in cortical grey and normal-appearing white matter in clinically early relapsing-remitting multiple sclerosis. , 2002, Brain : a journal of neurology.
[37] Hompson,et al. A LONGITUDINAL STUDY OF ABNORMALITIES ON MRI AND DISABILITY FROM MULTIPLE SCLEROSIS , 2002 .
[38] M. Filippi,et al. Inflammation in multiple sclerosis: the good, the bad, and the complex , 2002, The Lancet Neurology.
[39] F Barkhof,et al. The role of MRI as a surrogate outcome measure in multiple sclerosis , 2002, Multiple sclerosis.
[40] Mark A. van Buchem,et al. MT: magnetization transfer , 2003 .
[41] G R Wayne Moore,et al. MRI-clinical correlations: more than inflammation alone-what can MRI contribute to improve the understanding of pathological processes in MS? , 2003, Journal of the neurological sciences.
[42] A. Thompson,et al. New T2 lesions enable an earlier diagnosis of multiple sclerosis in clinically isolated syndromes , 2003, Annals of neurology.
[43] J. Frank,et al. The role of nonconventional magnetic resonance imaging techniques in demyelinating disorders , 2003, Current neurology and neuroscience reports.
[44] G J Barker,et al. Quantitative magnetization transfer mapping of bound protons in multiple sclerosis , 2003, Magnetic resonance in medicine.
[45] G. Moore. MRI-clinical correlations: more than inflammation alone-what can MRI contribute to improve the understanding of pathological processes in MS? , 2003, Journal of the Neurological Sciences.
[46] G J Barker,et al. Stereotactic co‐registration of magnetic resonance imaging and histopathology in post‐mortem multiple sclerosis brain , 2003, Neuropathology and applied neurobiology.
[47] Massimo Filippi,et al. The use of quantitative magnetic-resonance-based techniques to monitor the evolution of multiple sclerosis , 2003, The Lancet Neurology.
[48] Frederik Barkhof,et al. Remyelinated lesions in multiple sclerosis: magnetic resonance image appearance. , 2003, Archives of neurology.
[49] R. Ordidge,et al. High field MRI correlates of myelin content and axonal density in multiple sclerosis , 2003, Journal of Neurology.
[50] P. Tofts. Quantitative MRI of the Brain , 2003 .
[51] Moses Rodriguez. A function of myelin is to protect axons from subsequent injury: implications for deficits in multiple sclerosis. , 2003, Brain : a journal of neurology.
[52] G. Barker,et al. Evidence for grey matter MTR abnormality in minimally disabled patients with early relapsing-remitting multiple sclerosis , 2004, Journal of Neurology, Neurosurgery & Psychiatry.
[53] Penny A. Gowland,et al. T1: The Longitudinal Relaxation Time , 2004 .
[54] M. Maier. Quantitative MRI of the brain—measuring changes caused by disease , 2004 .
[55] Rajiv Midha,et al. MR properties of excised neural tissue following experimentally induced inflammation , 2004, Magnetic resonance in medicine.